Private Advisor Group’s Integra LifeSciences IART Stock Holding History

Private Advisor Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,007	Closed	-$268K	–	2177
2021 Q4	$268K	Sell	4,007 -4,331	-52%	-$293K	﹤0.01%	1787
2021 Q3	$572K	Buy	8,338 +4,259	+104%	+$301K	﹤0.01%	1448
2021 Q2	$278K	Buy	4,079 +434	+12%	+$30.7K	﹤0.01%	1668
2021 Q1	$252K	Buy	+3,645	New	+$247K	﹤0.01%	1638
2020 Q3	–	Sell	-275	Closed	-$13K	–	2441
2020 Q2	$13K	Buy	+275	New	+$13.5K	﹤0.01%	2795

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Private Advisor Group's IART Position: Q1 2022 in Review

Private Advisor Group sold out of Integra LifeSciences (IART) in Q1 2022, closing a stake of 4,007 shares — an estimated $268K sold.

Private Advisor Group first reported a position in IART in Q2 2020 and held it in 5 quarters. The position peaked at $572K in Q3 2021. 278 funds tracked by Wall St. Rank hold IART as of Q1 2022.

Private Advisor Group reported no remaining Integra LifeSciences position as of Q1 2022 after selling out during the quarter.
Private Advisor Group sold 4,007 Integra LifeSciences shares in Q1 2022, an estimated $268K.
Private Advisor Group first reported a position in Integra LifeSciences in Q2 2020 and held it in 5 quarters.
Private Advisor Group's Integra LifeSciences position peaked at $572K in Q3 2021.
278 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2022.

Based on Private Advisor Group's 13F filing for Q1 2022, filed 10 May 2022.